# Goldman Sachs Physical Gold ETF: financial statements, quarterly

AAAU · CBOE · CIK 1708646 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aaau.md) · [Financials](/companies/aaau/financials.md) · [Filings](/companies/aaau/filings.md) · [Insiders](/companies/aaau/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aaau/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Net income | $m | [(12.0)](/filings/0001193125-24-253120.md) | [56.1 d](/filings/0001193125-26-067559.md) | [42.7](/filings/0001193125-25-116016.md) | [32.8](/filings/0001193125-25-174363.md) | [94.5](/filings/0001193125-25-271745.md) | [(7.9) d](/filings/0001193125-26-067559.md) | [188](/filings/0001193125-26-216995.md) | [70.1](/filings/0001193125-26-340527.md) | [265](/filings/0001193125-25-271745.md) | [261 d](/filings/0001193125-26-067559.md) | [164](/filings/0001193125-26-216995.md) | [(353)](/filings/0001193125-26-340527.md) |
| Basic EPS | $ per share | [(0.39)](/filings/0001193125-24-253120.md) | not reported | [1.43](/filings/0001193125-25-116016.md) | [1.08](/filings/0001193125-25-174363.md) | [2.97](/filings/0001193125-25-271745.md) | not reported | [5.00](/filings/0001193125-26-216995.md) | [1.55](/filings/0001193125-26-340527.md) | [5.39](/filings/0001193125-25-271745.md) | not reported | [2.66](/filings/0001193125-26-216995.md) | [(5.74)](/filings/0001193125-26-340527.md) |

- Net income: us-gaap:NetIncomeLoss
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $m | [524](/filings/0001193125-23-273258.md) | [641](/filings/0001193125-25-036907.md) | [635](/filings/0001193125-24-135176.md) | [722](/filings/0001193125-24-195867.md) | [894](/filings/0001193125-24-253120.md) | [898](/filings/0001193125-26-067559.md) | [1,295](/filings/0001193125-25-116016.md) | [1,544](/filings/0001193125-25-174363.md) | [1,970](/filings/0001193125-25-271745.md) | [2,543](/filings/0001193125-26-340527.md) | [2,820](/filings/0001193125-26-216995.md) | [2,400](/filings/0001193125-26-340527.md) |
| Total liabilities | $m | [0.1](/filings/0001193125-23-273258.md) | [7.2](/filings/0001193125-25-036907.md) | [0.1](/filings/0001193125-24-135176.md) | [0.1](/filings/0001193125-24-195867.md) | [11.4](/filings/0001193125-24-253120.md) | [8.5](/filings/0001193125-26-067559.md) | [0.2](/filings/0001193125-25-116016.md) | [0.2](/filings/0001193125-25-174363.md) | [0.3](/filings/0001193125-25-271745.md) | [0.4](/filings/0001193125-26-340527.md) | [0.5](/filings/0001193125-26-216995.md) | [0.4](/filings/0001193125-26-340527.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $ | [0.0](/filings/0001193125-24-253120.md) | [0.0 d](/filings/0001193125-26-067559.md) | [0.0](/filings/0001193125-25-116016.md) | [0.0](/filings/0001193125-25-174363.md) | [0.0](/filings/0001193125-25-271745.md) | [0.0 d](/filings/0001193125-26-067559.md) | [0.0](/filings/0001193125-26-216995.md) | [0.0](/filings/0001193125-26-340527.md) | [0.0](/filings/0001193125-25-271745.md) | [0.0 d](/filings/0001193125-26-067559.md) | [0.0](/filings/0001193125-26-216995.md) | [0.0](/filings/0001193125-26-340527.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

Shares outstanding: 61,055,722 at 2026-08-03, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-340527.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.